Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 0 | 9.997.114 | 448.750 | 1 | ||
2019 | 0 | 8.713.395 | 2.285.375 | 1 |
Total number of partners: 27
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 27
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-05-01 | ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC | END-VOC | participant | 9.997.114 | 21 |
2019-09-01 | Collaboration for innovation: Establishment of a pan-nematode drug development platform | HELP | participant | 8.713.395 | 8 |